BMC Psychiatry

official impact factor 2.89

Open Access Highly Access Email this article to a friend

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Douglas Faries, Haya Ascher-Svanum*, Baojin Zhu, Christoph Correll and John Kane

BMC Psychiatry 2005, 5:26 doi:10.1186/1471-244X-5-26

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.